| Literature DB >> 33604874 |
Nader Akbari Dilmaghani1, Bashdar Mahmud Hussen2, Saeedeh Nateghinia1, Mohammad Taheri3, Soudeh Ghafouri-Fard4.
Abstract
Amyotrophic lateral sclerosis (ALS) is a deadly motor neuron disease (MND) and the most frequent MND in adults. ALS is recognized by degenerative alterations in both upper and lower motor neurons. This disorder is classified to familial and sporadic classes. Disease-causing mutations in SOD1, C9ORF72, FUS, and TARDBP have been recognized in familial ALS cases. However, in spite of conduction of several genetic association studies, heritable genetic risk elements in sporadic have not been identified completely. Several miRNAs have been dysregulated in the serum samples or brain tissues of ALS patients. Moreover, a number of miRNAs have been suggested as putative biomarkers for sporadic ALS. In the current manuscript, we review of miRNAs in the development of ALS.Entities:
Keywords: Amyotrophic lateral sclerosis; Biomarker; SOD1; miRNA; microRNA
Mesh:
Substances:
Year: 2021 PMID: 33604874 DOI: 10.1007/s11011-021-00697-5
Source DB: PubMed Journal: Metab Brain Dis ISSN: 0885-7490 Impact factor: 3.584